97 related articles for article (PubMed ID: 9579582)
1. Interferon-alpha and -gamma inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing Src tyrosine kinase activity.
Fujishima H; Nakano S; Tatsumoto T; Masumoto N; Niho Y
Int J Cancer; 1998 May; 76(3):423-9. PubMed ID: 9579582
[TBL] [Abstract][Full Text] [Related]
2. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
[TBL] [Abstract][Full Text] [Related]
3. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line.
Murakami Y; Nakano S; Niho Y; Hamasaki N; Izuhara K
J Cell Physiol; 1998 May; 175(2):220-8. PubMed ID: 9525481
[TBL] [Abstract][Full Text] [Related]
5. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.
Masumoto N; Nakano S; Fujishima H; Kohno K; Niho Y
Int J Cancer; 1999 Mar; 80(5):731-7. PubMed ID: 10048975
[TBL] [Abstract][Full Text] [Related]
6. Suppression of anoikis by v-Src but not by activated c-H-ras in human gallbladder epithelial cells.
Hisano C; Tanaka R; Fujishima H; Ariyama H; Tsuchiya T; Tatsumoto T; Mitsugi K; Nakamura M; Nakano S
Cell Biol Int; 2003; 27(5):415-21. PubMed ID: 12758089
[TBL] [Abstract][Full Text] [Related]
7. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.
Chang YJ; Holtzman MJ; Chen CC
Mol Pharmacol; 2004 Mar; 65(3):589-98. PubMed ID: 14978237
[TBL] [Abstract][Full Text] [Related]
8. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
Boudny V; Nakano S
Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
[TBL] [Abstract][Full Text] [Related]
9. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
[TBL] [Abstract][Full Text] [Related]
10. Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2.
Boudny V; Nakano S
Br J Cancer; 2002 Feb; 86(3):463-9. PubMed ID: 11875716
[TBL] [Abstract][Full Text] [Related]
11. Suppression of v-Src transformation in primary rat embryo fibroblasts.
Inoue H; Tavoloni N; Hanafusa H
Oncogene; 1995 Jul; 11(2):231-8. PubMed ID: 7624140
[TBL] [Abstract][Full Text] [Related]
12. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
He H; Hirokawa Y; Levitzki A; Maruta H
Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
[TBL] [Abstract][Full Text] [Related]
13. UCS15A, a non-kinase inhibitor of Src signal transduction.
Sharma SV; Oneyama C; Yamashita Y; Nakano H; Sugawara K; Hamada M; Kosaka N; Tamaoki T
Oncogene; 2001 Apr; 20(17):2068-79. PubMed ID: 11360191
[TBL] [Abstract][Full Text] [Related]
14. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
[TBL] [Abstract][Full Text] [Related]
15. Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol.
Kwon HJ; Yoshida M; Fukui Y; Horinouchi S; Beppu T
Cancer Res; 1992 Dec; 52(24):6926-30. PubMed ID: 1458481
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
Kalakonda S; Nallar SC; Gong P; Lindner DJ; Goldblum SE; Reddy SP; Kalvakolanu DV
Am J Pathol; 2007 Oct; 171(4):1352-68. PubMed ID: 17823279
[TBL] [Abstract][Full Text] [Related]
18. Activation of YRP kinase by v-Src and protein kinase C-mediated signal transduction pathways.
Scholz G; Felder MP; Hanafusa H
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2592-6. PubMed ID: 7535926
[TBL] [Abstract][Full Text] [Related]
19. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.
Watling D; Guschin D; Müller M; Silvennoinen O; Witthuhn BA; Quelle FW; Rogers NC; Schindler C; Stark GR; Ihle JN
Nature; 1993 Nov; 366(6451):166-70. PubMed ID: 7901766
[TBL] [Abstract][Full Text] [Related]
20. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins.
Shuai K; Ziemiecki A; Wilks AF; Harpur AG; Sadowski HB; Gilman MZ; Darnell JE
Nature; 1993 Dec; 366(6455):580-3. PubMed ID: 7504784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
